drugset / Trial / NCT05570409
Immunosuppressive Treatment in Chronic Virus-Negative Inflammatory Cardiomyopathy
Phase 2/3
Terminated
9 enrolled
LMU Klinikum
Charite University, Berlin, Germany · collabDeutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) · collabTechnical University of Munich · collabUniversity Hospital Erlangen · collabUniversity Hospital Tuebingen · collabUniversity Hospital, Essen · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Evaluating Immunosuppressive treatment (Mycophenolate mofetil and prednisolon compared to placebo) for 6 months in patients with chronic virus- Negative Inflammatory cardiomyopathy - a multicenter, randomized, double-blind, placebo-controlled trial.
Timeline
- Start
- 2023-03-28
- Primary completion
- 2025-04-14
- Completion
- 2025-04-14
Outcome
Outcome not reported
Stopped (Enrollment): “Premature end of recruitment due to lack of eligible patients. Within two years of recruitment only nine patients could be randomized out of 130 required patients as per trial protocol.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mycophenolate Mofetil | Small molecule | 1 g | — |
| Subject | Prednisolone | Other / unclassified | 1 mg/kg | — |